相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes
Zhiyu He et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein
Jungmin Chun et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization
Jayoung Kim et al.
ACTA BIOMATERIALIA (2019)
A non-covalent antibody complex for the delivery of anti-cancer drugs
Katia Maso et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing
Yuan Rui et al.
SCIENCE ADVANCES (2019)
One-month zero-order sustained release and tumor eradication after a single subcutaneous injection of interferon alpha fused with a body-temperature-responsive polypeptide
Zhuoran Wang et al.
BIOMATERIALS SCIENCE (2019)
Glucose-Responsive Trehalose Hydrogel for Insulin Stabilization and Delivery
Juneyoung Lee et al.
MACROMOLECULAR BIOSCIENCE (2018)
Site-Specific Insulin-Trehalose Glycopolymer Conjugate by Grafting from Strategy Improves Bioactivity
Kathryn M. Mansfield et al.
ACS MACRO LETTERS (2018)
Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery
Angela M. Wagner et al.
ACTA PHARMACEUTICA SINICA B (2018)
A guide to maximizing the therapeutic potential of protein-polymer conjugates by rational design
Jeong Hoon Ko et al.
CHEMICAL SOCIETY REVIEWS (2018)
Covalent immobilisation of transglutaminase: stability and applications in protein PEGylation
Antonella Grigoletto et al.
JOURNAL OF DRUG TARGETING (2017)
Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model
D. Levin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins
Xi Zhu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Site-specific in situ growth of an interferon-polymer conjugate that outperforms PEGASYS in cancer therapy
Jin Hu et al.
BIOMATERIALS (2016)
Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release
Rene Rietscher et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery
Michael Clinton Koetting et al.
JOURNAL OF CONTROLLED RELEASE (2016)
In situ growth of a C-terminal interferon-alpha conjugate of a phospholipid polymer that outperforms PEGASYS in cancer therapy
Jin Hu et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Nanotechnology for protein delivery: Overview and perspectives
Mikyung Yu et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Enhancing Pharmacokinetics, Tumor Accumulation, and Antitumor Efficacy by Elastin-Like Polypeptide Fusion of Interferon Alpha
Jin Hu et al.
ADVANCED MATERIALS (2015)
Site-specific in situ growth of a cyclized protein-polymer conjugate with improved stability and tumor retention
Jin Hu et al.
BIOMATERIALS (2015)
Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers
Jun Wu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Therapeutic applications of hydrogels in oral drug delivery
Lindsey A. Sharpe et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins
Won Il Choi et al.
NANO LETTERS (2014)
Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs
Yosuke Hashimoto et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide
Ron B. Shmueli et al.
BIOMATERIALS (2013)
Characterizing the Impact of Renal Impairment on the Clinical Pharmacology of Biologics
Bernd Meibohm et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
FDA-approved poly(ethylene glycol)-protein conjugate drugs
Steevens N. S. Alconcel et al.
POLYMER CHEMISTRY (2011)
The N-terminal alanine-extended GLP-1/IgG-Fc fusion protein confers resistance to DPP-IV and reduces serum glucose level in db/db mice
Hye-Shin Chung et al.
REGULATORY PEPTIDES (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Anti-cancer PEG-enzymes: 30 years old, but still a current approach
Gianfranco Pasut et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Albinterferon α-2b:: a genetic fusion protein for the treatment of chronic hepatitis C
G. Mani Subramanian et al.
NATURE BIOTECHNOLOGY (2007)
Size comparison between proteins PEGylated with branched and linear Poly(Ethylene glycol) molecules
Conan J. Fee
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-α2b fusion protein expressed in Pichia pastoris
Yan-Shan Huang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice
RJ Melder et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-α2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2
C Dhalluin et al.
BIOCONJUGATE CHEMISTRY (2005)
Peptide and protein drug delivery to and into tumors: challenges and solutions
VP Torchilin et al.
DRUG DISCOVERY TODAY (2003)
分享论文
